A key role exists for prostaglandins (PGs) in reproductive health, including fertility and parturition. However, the cellular sources and regulation of PG production by cyclooxygenase (COX) in the human female reproductive tract remain poorly understood. We recently reported that human female reproductive tract fibroblasts are divisible into distinct subsets based on their Thy-1 surface expression. Herein, we demonstrate that the expression, induction and subcellular localization of COX-1 and COX-2, and downstream PG biosynthesis are markedly different between these subsets. Specifically, Thy-1 + fibroblasts highly express COX-1, which is responsible for high-level PGE 2 production, a feature usually attributed to the COX-2 isoenzyme.
Introduction
Critical events in the human female reproductive tract such as ovulation, implantation and parturition are characterized by inflammation (9) . Close interaction among the different cell layers that form the uterus, namely the endometrium and myometrium, is required for successful outcome of these events and is crucial for human existence. Besides cytokines and sex steroid hormones, prostaglandins (PGs) play a central role in the normal functioning of the reproductive tract in processes such as ovulation (7), menstruation (9, 18) , implantation (24) and parturition (25) .
PGs are arachidonic acid metabolites, crucial for normal physiology and for inciting and regulating inflammatory responses. Prostanoid biosynthesis is catalyzed by two cyclooxygenases (COX), COX-1 and COX-2. COX-1 is considered to be a constitutively expressed enzyme that maintains cellular homeostasis, while COX-2 is typically induced following stimulation with certain bacterial products and proinflammatory cytokines such as IL-1 and plays a major role in inflammation (40) . The various types of PGs are ultimately synthesized by newly characterized synthases that may be differentially expressed among cells and tissues (16) .
The study of COXs and PGs comprises a vast area of research in the biology of reproduction. PGs are essential for parturition in mice (12) and are crucial for initiating labor in humans (28, 44) . A key PG, called PGE 2 , is crucial for inflammation, for reproductive tract functions, and for fetal organ maturation (33) . COX expression is vital for "cervical ripening", a process of neutrophil tissue infiltration, essential for normal labor (17) . COX-1 has also been shown to be critical for normal labor in the mouse, as COX-1 deficient mice demonstrated delayed parturition resulting in neonatal death (12) . COX-1 and COX-2 mRNA is expressed in cow myometrium (11) and COX-1 and COX-2 protein exists at high levels in the human myometrium (41) . Increased levels of COX-2 in the myometrium are associated with onset of labor in women (8) .
The concept of fibroblasts as "sentinel cells" has provided a new role for them as initiators of inflammation and regulators of immunity (5, 32, 37) . Resident tissue fibroblasts produce proinflammatory cytokines and PGs upon stimulation and thus recruit and communicate with classic immune cells. Fibroblasts themselves, however, remain poorly understood and were previously considered to be only structural cells with little intrinsic heterogeneity. An emerging concept is that fibroblasts are not a homogeneous population, but rather consist of subsets that have organ-specific functions. For example, fibroblasts are heterogeneous with respect to expression of the surface antigen Thy-1 in several organs, including mouse lung (31) and spleen (4) , rat lung (26) and human orbit (39). Little is known, however, about fibroblasts derived from the human female reproductive tract. We recently demonstrated that fibroblasts derived from human myometrium are heterogeneous, and subsets separated based on Thy-1 expression have distinct cytokine and chemokine profiles (21) . In the current study, we investigated COX-1 and -2 expression by Thy-1 + and Thy-1 -human myometrial fibroblasts. We demonstrate that myometrial fibroblast subsets have distinct COX expression patterns, subcellular localization and signal transduction pathways, as well as PG production. The findings in this report support the concept that human myometrial fibroblast subpopulations contribute uniquely to reproductive tract processes associated with inflammation. Our results have important implications in the manner reproductive tract fibroblasts are viewed. In light of the evidence presented herein, myometrial fibroblasts should now be viewed as key players in PG homeostasis as well as in the initiation of inflammatory events in the reproductive tract.
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Materials and Methods
Tissue Collection and fibroblast strain derivation
Tissue samples were obtained as previously described (19) . In brief, biopsies were collected from myometrium in women undergoing gynecological procedures for benign conditions. All women had regular menstrual cycles (25-35 days), were pre-menopausal years old) and did not receive any form of hormonal treatment in the three months prior to the procedure. Written informed consent was received from all patients and ethical approval was obtained from the University of Rochester research subjects review board.
Tissue was cut into 1mm 3 pieces, and fibroblast cultures were established by standard explant techniques as previously described (10, 35) . The cells were immunostained for fibroblast markers as previously described (19, 21) . In brief, cells were positive for vimentin (fibroblast marker), but negative for cytokeratin (epithelial cell marker), α-smooth muscle actin (myofibroblasts and smooth muscle cells), CD34 (endothelial cell marker) and CD45 (bone marrow derived cell marker). The cells that proliferated under these conditions had fibroblast morphology and were not contaminated with other cell types. There was no mycoplasma contamination in the cultures. All cells used in experiments were early passage (passages 4-11).
Myometrial fibroblast strains were cultured in RPMI 1640 media (Life Technologies, Gaithersburg, MD) supplemented with 10% FBS (Hyclone Laboratories, Logan, UT), 0.1 mM non-essential amino acids and 0.048 mg/ml gentamicin (Life Technologies, Gaithersburg, MD).
As previously described, fibroblast subset separation was accomplished by first sorting with FACS according to Thy-1 expression, followed by 3-4 rounds of magnetic bead selection (21 
RNA Isolation and RNase Protection Assay
Total RNA was isolated from myometrial fibroblast subsets at 0, 1, 2, 4, 6, 8 and 18
hours following IL-1β treatment, using TRI-reagent (Molecular Research Center, Inc. Cincinnati, OH). Eight µg RNA was used for each sample to hybridize with the probe. COX-1 (human) Vector Labs, Burlingame, CA) was added as a secondary antibody and streptavidin-horseradish peroxidase (1:1000; Jackson Immunoresearch Labs, West Grove, PA) was added as a substrate.
Samples were visualized by adding an aminoethyl-carbachol (AEC) chromogen (Zymed, South San Fransisco, CA) and cover-slipped using Immu-mount (Shandon, Pittsburgh, PA). For COX-1 and -2 immunohistochemistry, fresh myometrial tissue samples were fixed in neutral buffered formalin, embedded in paraffin and 5 µm serial sections were cut. Staining for COX-1 and -2 was completed as above. Sections were counterstained with hematoxylin. For Western blot analysis, monoclonal mouse anti-human COX-1 and mouse anti-human COX-2 antibodies were used at 50 ng/ml.
PG Production
Fibroblasts were treated as described above. PGE 2 production was assayed using an enzyme immunoassay (Cayman Chemicals, Ann Arbor, MI). Two hours before the addition of IL-1β, cultures were treated with ethanol (vehicle control), indomethacin (10 µM; Sigma, St.
Louis, MO), SC58125 (5 µM) or SC58560 (0.5 µM). SC58560 and SC58125 were kind gifts from Dr. Peter Isakson (Searle, Skokie, IL).
Western Blot Analysis
Cells were treated as above for COX 1 and COX-2 analysis, or treated with IL-1β (10 ng/ml) and harvested in a timecourse at 1, 2, 5, 15, 30 min, 1, and 6 hours for ERK 1 (p42), ERK 2 (p44), and p38 MAP Kinase analysis. The ERK 1/2 inhibitor PD98059 (Calbiochem, San Diego, CA) inhibits MEK1 activation and phosphorylation of ERK1/2, and was added at 50 µM at the indicated timepoints or overnight. The p38 inhibitor SB203580 (Calbiochem, San Diego, CA) was also added at 50µM overnight. DMSO was added as vehicle control to untreated cells.
Equal amounts of fibroblast protein lysates were subjected to Western blot analysis as previously described (36) 
Statistical analysis
Statistical significance was determined using the student's paired two-tailed t-test or a generalized linear model analysis, where p<0.05 indicates statistical significance between the samples tested. Log transformation was performed to correct for variance.
Results
COX-1 and COX-2 mRNA expression by myometrial fibroblast subsets
Fibroblasts are one of the main cell types responsible for PG production via expression of COX-1 and COX-2 (5, 46). COXs are also central for homeostasis in the reproductive tract (17, 29) . For these reasons, we first examined whether or not Thy-1 COX-1 and COX-2 mRNA levels were quantitated by normalizing to β-actin using an RNase protection assay. Thy-1 + myometrial fibroblasts expressed COX-1 mRNA constitutively, while COX-2 mRNA was absent in untreated cells, but was greatly upregulated following IL-1β treatment (10 ng/ml) (Fig. 1A,B) . COX-1 mRNA levels in myometrial Thy-1 -fibroblasts were relatively unchanged throughout the IL-1β timecourse. Interestingly, constitutive COX-2 mRNA levels were detected in Thy-1 -myometrial fibroblasts and surprisingly were not affected by IL-1β treatment (Fig. 1C,D) . This is an intriguing finding, as COX-2 is thought of as an inducible enzyme, associated with inflammatory processes.
COX-1 and -2 protein expression by Western blot
Western blot analysis was next performed on untreated and IL-1β-stimulated (24 hours (Fig. 3A) . COX-2 expression in the Thy-1 + subpopulation was almost non-existent in the untreated cells, but was upregulated in a heterogeneous manner after IL-1β stimulation (Fig. 3A) . This induction of COX-2 after IL-1β is typical for fibroblastic cells (Fig. 3B) . COX-2 staining in the Thy-1 -cells revealed a cytoplasmic localization and interestingly, it was not affected by IL-1β. This apparent constitutive COX-2 expression (Fig. 3A) is unexpected, but correlates with the Western blot COX-2 protein expression in Figure 2 . For comparison, human lung fibroblasts showing "typical" COX-1 and COX-2 staining patterns in untreated and IL-1β-stimulated cells are shown in Figure 3B .
COX-1 and COX-2 expression in human myometrium
In situ staining for COX-1 and COX-2 was performed on human myometrium tissue sections. Immunohistochemistry revealed both COX-1 and -2 to be expressed in human myometrium (Fig. 4) . COX-1 was observed throughout the tissue and was also localized to single fibroblastic cells embedded in a field of collagen, as indicated by inserted arrows in Figure   4A . COX-1 localization was also apparent in the structural cells surrounding blood vessels throughout the tissue (data not shown). COX-1 was additionally expressed on smooth muscle cell bundles of the myometrium, as shown by the arrowhead (Fig. 4A ). COX-2 was highly expressed by individual fibroblasts in the stroma of the myometrium. Single fibroblasts set in a collagen matrix stained positive for COX-2 as indicated by arrows (Fig. 4B) inhibitor reduced most of the IL-1β-stimulated PGE 2 production.
ERK1, ERK2 and p38 MAP Kinase phosphorylation in myometrial fibroblast subsets
Previous studies demonstrated a role for ERK1 (p42) and ERK2 (p44) MAP kinases in response to IL-1β, as well as in the signaling pathway for COX-2, but not COX-1 (1, 23). The MAP Kinase p38 is also involved in inflammation-type responses and can participate in COX-2 induction (14). We first determined phosphorylation of ERK1, ERK2 and p38 in the myometrial fibroblast subsets after an IL-1β time-course. The MEK1 inhibitor PD98059 (50 µM) was included at each time-point to ascertain its blocking effect on phosphorylation of ERK1/2.
Interestingly, the two subsets displayed differential regulation of ERK1 and ERK2. Thy-1 + fibroblasts showed sustained phosphorylation of ERK1 and ERK2, which peaked at 5-30 minutes after IL-1β treatment and subsided by 6 hours (Fig. 6A) . Thy-1 -fibroblasts had a more transient ERK phosphorylation that peaked by 5 minutes after IL-1β stimulation and disappeared by 15 minutes (Fig. 6A) . Also, in the case of Thy-1 -cells, ERK1 was phosphorylated first at the 1 and 2 minute time-points, while ERK2 only peaked at 5 minutes together with ERK1.
PD98059 inhibited IL-1β-induced ERK phosphorylation in both subsets. Both myometrial fibroblast subpopulations showed IL-1β-induced p38 phosphorylation, even though the p38 timecourse also varied between the subsets (Fig. 6B) We next examined whether ERK1/2 or p38 MAP Kinases were involved in the signaling pathway of COX-1 or COX-2 expressed by the myometrial fibroblast subpopulations.
Myometrial fibroblast subsets were treated with IL-1β (10 ng/ml) for 18 hours, with or without the MEK1 inhibitor PD98059 (50 µM), to determine the effect of ERKs on COX-1 and COX-2 expression. To determine the effect of p38 signaling on COX-1 and COX-2, the downstream p38 inhibitor SB203580 (50 µM) was employed. As anticipated, COX-1 expression was not affected by PD98059 or SB203580 in either subset (Fig. 7) . IL-1β-induced COX-2 expression was completely abolished by addition of PD98059 in Thy-1 + fibroblasts, implicating ERK1 and ERK2 in its regulation (Fig. 7) . However, PD98059 had no effect on COX-2 expression in Thy- is also a signaling pathway utilized for COX-2 induction in this subset. Similar to PD98059, the p38 inhibitor, SB203580, had no effect on COX-2 expression in Thy-1 -fibroblasts, also excluding this MAP Kinase from maintaining constitutive COX-2 in Thy-1 -cells. The same results described above on the effect of ERKs and p38 MAP Kinase pathways on COX-1 and COX-2, were observed using immunocytochemistry (data not shown).
Discussion
Fibroblasts are dynamic cells whose functions and characteristics differ according to their anatomic location and the environment to which they are exposed. Variations in fibroblast responses from tissue to tissue and within a single tissue can now be explained by the existence of subsets within a fibroblast population. The data contained herein support the concept that two types of fibroblasts inhabit the human myometrium and these subsets have unique roles in producing PGs, seminal mediators of inflammatory responses and reproductive tract functions. account for the low PGE 2 production. Another possibility is that this form of COX-2 acts as a preformed "precursor" pro-enzyme that awaits a stimulus for its activation and a robust synthesis of PGs.
Labor is associated with increased COX-2 expression in uterine tissues (29, 43) . COX-2 expression is suggested to be responsible for induction of PGF2α (33), which is a vasoconstrictor and responsible for labor induction in mice (42) . Specifically, the primary role of the myometrium is to provide contractions during labor. In our studies, the Thy-1 + myometrial subset was capable of increased PGF2α production with IL-1β stimulation, and this was mainly via COX-2, as determined using COX selective inhibitors (data not shown). Given that the COX general inhibitor, indomethacin, is widely and successfully used to prevent preterm delivery in humans, a role implicating COXs is suggested. Furthermore, studies administering the COX-2 selective drug nimesulide in sheep, showed a delay in delivery when labor was induced in ewes (33) . COX-2 selective inhibitors were also shown to inhibit spontaneous uterine contractions in the rat (34) . Our results provide insight to these reports, and suggest the potential use of a COX-2 selective drug to prevent preterm labor. In this way fetal well-being is less likely to be compromised, as inhibition of COX-1-derived PGE 2 will not occur. Alternatively, premature contractions may be better inhibited by selectively blocking COX-2 and PGF2α. However, care
should be taken in this assessment as the function of constitutive COX-2 in the myometrium remains to be elucidated.
In 
FIGURE 3
Localization of COX-1 and COX-2 in fibroblast subsets. COX-1 and -2 expression was determined by immunocytochemistry as described in Methods. Isotype controls were also used at 10 µg/ml and showed no staining (data not shown). 
FIGURE 4
Immunohistochemical localization of COX-1 and -2 in human myometrium. Fresh myometrial tissue samples were fixed in formalin, paraffin-embedded, and 5 µm thick sections were cut.
Immunohistochemistry was performed as described in Methods. • Low PGE 2 /PGF2α production • ERK1/2 induced; no effect on COX-2 expression • p38 induced; no effect on COX-2 expression Table 1 Summary of key COX and prostaglandin expression patterns and signal transduction conduits in 
